NBI files charges against Pnoy, Abad,& Garin over P3.5B Dengvaxia purchase

NBI files charges against Pnoy, Abad,& Garin over P3.5B Dengvaxia purchase


 

The wheels of justice is moving….. though slowly it is - moving.

 

After conducting its own investigations based on the order of former Justice Secretary Vitaliano Aguirre II to dig deeper on the matter regarding the controversial vaccine.

 

The National Bureau of Investigation has filed charges against former President Benigno Noynoy” Aquino III, two former Cabinet officials, and several former and incumbent officials of the Department of Health (DOH) and private individuals in connection with the PHP3.5 billion anti-dengue drive of the agency and French pharmaceutical giant Sanofi Pasteur, maker of the controversial Dengvaxia vaccine.

 
Former Pres. Aquino, Budget Sec. Butch Abad , and Health Sec. Janette Garin (photo credit to owner)

The NBI has asked the Ombudsman to conduct a preliminary investigation on the complaint for graft and corrupt practices and other criminal offenses against the personalities connected with the Dengvaxia scandal staring with the former President.

 

NBI Director Dante Gierran drafted a letter addressed to outgoing Ombudsman Conchita Carpio-Morales, recommending a conduct of preliminary investigation against Aquino and his co-respondents including former budget secretary Florencio Abad, former health secretary Janette Garin for conniving to introduce the Dengvaxia vaccine in the country by circumventing procurement and other government processes.

 

NBI also sought for the prosecution of Aquino for technical malversation under Article 220 of the Revised Penal Code (RPC) “by his authority, declared the use of savings from the FY2015 Mutual Benefit Personnel Fund and use the same to ‘augment’ a non-existent anti-dengue immunization program.”

 

The NBI also said that Aquino, Abad, and Garin should be held accountable for technical malversation for conspiring to unlawfully effect the release of savings from the fiscal year 2015 Mutual Benefit Personnel Fund and use the same to augment the anti-dengue immunization program.

“Review of the 2015 GAA (General Appropriations Act) finds no reference to any item or program, activity or project for the procurement of anti-dengue vaccine in particular,” the NBI said.

The controversial vaccine was purchaesd for 3.5 Billion and was used in the mass vaccination program of the government to Filipino school children, 830, 000 of them.

“Parents of vaccinated children, regardless of status, was shaken by the latest discovery of Sanofi Pasteur, Inc. (SPI) that the Dengvaxia should not be introduced to seronegative individuals,” the NBI said.

As per Public Attorney’s Office chief Atty. Persida Acosta, there are already over 200 deaths which can be attributed to Dengvaxia.

 

What can you say about this?

Share us your thoughts by simply leaving on the comment section below. For more news updates, feel free to visit our site often.

Stay updated with today's relevant news and trends by hitting the LIKE button.  

Thanks for dropping by and reading this post.

Report from PNA

Post a Comment

0 Comments